Skip to main content
Clinical Trials/NL-OMON52222
NL-OMON52222
Completed
Not Applicable

Optimal postoperative Pain management After Lung surgery (OPtriAL): multi-centre randomised trial - OPtriA

Maxima Medisch Centrum0 sites420 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
postoperative pain
Sponsor
Maxima Medisch Centrum
Enrollment
420
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • Patients referred for anatomical lung resection (pneumonectomy, (bi)lobectomy
  • or segmentectomy) with the intention of performing it by VATS or RATS are
  • eligible for the trial. Adult patients older than 18 years who are able to give
  • informed consent and fill out questionnaires in Dutch.

Exclusion Criteria

  • Patients with contra\-indications for TEA or PVB (infection at skin site,
  • increased intracranial pressure, non\-correctable coagulopathy, sepsis and
  • mechanical spine obstruction) or allergic reactions to local anaesthetics will
  • be excluded. Patients chronically using opioids for reasons not related to the
  • operation will be excluded from the study since postoperative baseline opioid
  • requirement will be higher and TEA remains the preferred technique for these
  • patients. If, prior to the procedure, catheter placement during TEA is
  • unsuccessful, a continuous PVB will be given during the procedure, and, if
  • catheter placement during PVB is unsuccessful, a single shot multilevel ICNB
  • will be used. Non\-inferiority will be analysed based on intention\-to\-treat, as

Outcomes

Primary Outcomes

Not specified

Similar Trials